Get started
Amgen Inc. 2.77% 01-SEP-2053Amgen Inc. 2.77% 01-SEP-2053Amgen Inc. 2.77% 01-SEP-2053

Amgen Inc. 2.77% 01-SEP-2053

No trades
See on Supercharts
Overview
Analysis News

AMGN5032329 chart


Full chart

Key terms


Outstanding amount
‪81.00 K‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
2.77% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
3.36%
Maturity date
Sep 1, 2053
Term to maturity
28 years

About Amgen Inc. 2.77% 01-SEP-2053


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Aug 17, 2020
FIGI
BBG00WPL8JF9
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGN5032329 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

AMGN5032329 news